Reassessing ASCT in patients aged 65–75 with multiple myeloma in the era of anti-CD38 therapies
Angelo Belotti, P. Maestri, Sofia Terlizzi, Rossella Ribolla et autres
it (code pays fourni par la source)
0 citations
Blood
Samantha Ferrari
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
22Publications signalées
423Citations signalées
1Affiliations récentes
Les institutions déclarées
Les domaines associés
Multiple Myeloma Research and TreatmentsChronic Lymphocytic Leukemia ResearchChronic Myeloid Leukemia TreatmentsCancer Treatment and PharmacologyLymphoma Diagnosis and Treatment
Les publications récentes
Early identification of functional high-risk multiple myeloma patients after transplant: the predictive power of fat fraction and Response Assessment Category score in diffusion-weighted whole-body magnetic resonance imaging
Angelo Belotti, Barbara Frittoli, Sofia Terlizzi, Rossella Ribolla et autres
it, us (code pays fourni par la source)
2 citations
Haematologica
Early Identification of Functional High Risk Multiple Myeloma Patients after Transplant with Diffusion-Weighted Whole-Body MRI: Predictive Role of Fat Fraction in Addition to RAC Score
Angelo Belotti, Barbara Frittoli, Sofia Terlizzi, Rossella Ribolla et autres
it (code pays fourni par la source)
1 citation
Blood
Predictive role of sustained imaging MRD negativity assessed by diffusion‐weighted whole‐body MRI in multiple myeloma
Angelo Belotti, Rossella Ribolla, Claudia Crippa, Marco Chiarini et autres
it (code pays fourni par la source)
12 citations
American Journal of Hematology
Failure to Achieve Sustained Imaging MRD Negativity Assessed By Diffusion-Weighted Whole-Body MRI (DW-MRI) Is Associated with Adverse Prognosis in Newly Diagnosed Multiple Myeloma Patients Treated with Autologous Stem Cell Transplantation Followed By Maintenance Therapy
Angelo Belotti, Rossella Ribolla, Claudia Crippa, Marco Chiarini et autres
it (code pays fourni par la source)
2 citations
Blood
Sustained Residual Disease Negativity Assessed By Diffusion-Weighted Whole-Body MRI (DW-MRI) Has Strong Predictive Relevance for Survival in Newly Diagnosed Multiple Myeloma Patients on Maintenance Therapy after Autologous Stem Cell Transplantation (ASCT)
Angelo Belotti, Rossella Ribolla, Alberta Villanacci, Marco Chiarini et autres
it (code pays fourni par la source)
1 citation
Blood
OAB-058: Predictive relevance of sustained MRD negativity and of early loss of MRD negativity during maintenance therapy after transplant in newly diagnosed Multiple Myeloma patients
Angelo Belotti, Rossella Ribolla, Marco Chiarini, Viviana Giustini et autres
it (code pays fourni par la source)
0 citations
Clinical Lymphoma Myeloma & Leukemia
Predictive role of diffusion‐weighted whole‐body MRI (DW‐MRI) imaging response according to MY‐RADS criteria after autologous stem cell transplantation in patients with multiple myeloma and combined evaluation with MRD assessment by flow cytometry
Angelo Belotti, Rossella Ribolla, Valeria Cancelli, Alberta Villanacci et autres
it (code pays fourni par la source)
42 citations
Cancer Medicine
Vemurafenib plus Rituximab in Refractory or Relapsed Hairy-Cell Leukemia
Enrico Tiacci, Edoardo Simonetti, Monia Capponi, Achille Ambrosetti et autres
it, lb (code pays fourni par la source)
125 citations
New England Journal of Medicine
External Validation of Diffusion Weighted Whole Body MRI (DW-MRI) Response Assessment Category (RAC) Criteria Proposed By the Myeloma Response Assessment and Diagnosis System (MY-RADS) Imaging Recommendations: Prognostic Role of Imaging Response after Transplant in Multiple Myeloma and Comparison with MRD Evaluation By Flow Cytometry
Angelo Belotti, Rossella Ribolla, Valeria Cancelli, Alberta Villanacci et autres
it (code pays fourni par la source)
5 citations
Blood
Transplant eligibility in elderly multiple myeloma patients: Prospective external validation of the international myeloma working group frailty score and comparison with clinical judgment and other comorbidity scores in unselected patients aged 65‐75 years
Angelo Belotti, Rossella Ribolla, Valeria Cancelli, Claudia Crippa et autres
it (code pays fourni par la source)
42 citations
American Journal of Hematology
R-Interferon Treatment before Imatinib Reverses the Negative Impact of e13a2 Transcript Type on Treatment Free Remission Duration after Tyrosine Kinase Inhibitors Discontinuation in Chronic Myeloid Leukemia Patients
Mariella D’Adda, Mirko Farina, Angela Passi, Rosa Daffini et autres
it, us (code pays fourni par la source)
0 citations
Blood
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.